Cardiac Output Monitor System from the Alfred Mann Institute at USC Ready for Licensing
Los Angeles, CA, December 04, 2009 --(PR.com)-- The Alfred Mann Institute at the University of Southern California (AMI-USC) is unveiling its new product ready for license: The AMI Cardiac Output and Blood Volume Monitor.
The AMI-USC worked with several outstanding inventors, Jean-Michel Maarek, PhD from USC, Daniel Holschneider, MD, from USC and Eduardo Rubinstein, MD from UCLA to develop a technology that has the ability of detecting hypotension in dialysis patients 30 to 45 minutes prior the onset of the event, based on the results of the preliminary trials.
This technology can have significant impact on the dialysis setting. Currently, the dialysis medical staff benefits from less than a 5 minute warning, when the patient is about to faint or experience some cardiac distress. This AMI technology
· Minimizes the number of hospitalizations,
· Increases the quality and comfort of care of the patients,
· Lowers the stress on the nursing staff, and
· Secures additional revenues for the dialysis centers by retaining their clients in their centers and thus helping their patients not miss sessions due to hospitalization.
This product reports absolute cardiac output within 30 seconds and absolute blood volume within 90 seconds as well as 9 other hemodynamic parameters. The solution is minimally invasive and self calibrating.
The technology has been applied successfully in a trial with 50 subjects by two prominent Nephronologists, Vito Campese, MD, head of the Department of Nephrology at USC, and Akmal Mohammad, MD, Director, Department of Medicine, DaVita/USC Kidney Center.
Beside the dialysis application, this technology has also great potential in Critical Care Management for early cardiac assessment in ICU when the patient only has a venous port access and a triage method for shock conditions in the Emergency Room setting.
The intellectual property is owned by the Alfred Mann Institute (AMI) at the University of Southern California and has been funded by AMI since 2002. AMI is a non-profit company, independent from the University, whose mission is to accelerate the development and commercialization of biomedical inventions is issued from USC. The Institute operates from a $100M endowment generously donated by philanthropic successful businessman, Alfred E. Mann.
To discuss the possibility of licensing this technology, contact Nathalie Gosset at 213-821-1339 or at gosset@usc.edu.
###
The AMI-USC worked with several outstanding inventors, Jean-Michel Maarek, PhD from USC, Daniel Holschneider, MD, from USC and Eduardo Rubinstein, MD from UCLA to develop a technology that has the ability of detecting hypotension in dialysis patients 30 to 45 minutes prior the onset of the event, based on the results of the preliminary trials.
This technology can have significant impact on the dialysis setting. Currently, the dialysis medical staff benefits from less than a 5 minute warning, when the patient is about to faint or experience some cardiac distress. This AMI technology
· Minimizes the number of hospitalizations,
· Increases the quality and comfort of care of the patients,
· Lowers the stress on the nursing staff, and
· Secures additional revenues for the dialysis centers by retaining their clients in their centers and thus helping their patients not miss sessions due to hospitalization.
This product reports absolute cardiac output within 30 seconds and absolute blood volume within 90 seconds as well as 9 other hemodynamic parameters. The solution is minimally invasive and self calibrating.
The technology has been applied successfully in a trial with 50 subjects by two prominent Nephronologists, Vito Campese, MD, head of the Department of Nephrology at USC, and Akmal Mohammad, MD, Director, Department of Medicine, DaVita/USC Kidney Center.
Beside the dialysis application, this technology has also great potential in Critical Care Management for early cardiac assessment in ICU when the patient only has a venous port access and a triage method for shock conditions in the Emergency Room setting.
The intellectual property is owned by the Alfred Mann Institute (AMI) at the University of Southern California and has been funded by AMI since 2002. AMI is a non-profit company, independent from the University, whose mission is to accelerate the development and commercialization of biomedical inventions is issued from USC. The Institute operates from a $100M endowment generously donated by philanthropic successful businessman, Alfred E. Mann.
To discuss the possibility of licensing this technology, contact Nathalie Gosset at 213-821-1339 or at gosset@usc.edu.
###
Contact
Alfred Mann Institute at the University of Southern California
Nathalie Gosset
213-821-1339
http://ami.usc.edu/
Nathalie Gosset
213-821-1339
http://ami.usc.edu/
Contact
Categories